Issues discussed in this podcast with Steve Mister, President & CEO of CRN include:

• • The drug exclusion rule in DSHEA and the impact on CBD, NAC, NMN, and other ingredients;

• • FDA restructuring of the Human Foods Program and industry’s relationship with its regulators;

• • FDA’s “Dietary Supplement Ingredient Directory”;

• • CBD and potential for a regulatory fix through the Farm Bill, or other legislative packages;

• • FTC notices sent to companies about claims substantiation and its Health Products Compliance Guidance;

• • Counterfeit products imitating dietary supplement brands and the potential impact on consumer trust;

• • Results from a consumer survey and efforts to cover dietary supplement costs with HSAs and FSAs (Health Savings Accounts and Flexible Spending Accounts).